Logos Global Management »

Longeveron shares owned by Logos Global Management

Quarter-by-quarter ownership of Longeveron (LGVN) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Longeveron

Tip: Access up to 7 years of quarterly data

All positions including Longeveron held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Longeveron by Logos Global Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $905k 1.3M 0.70

More positions owned by Logos Global Management

Erasca (ERAS)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Ideaya Biosciences (IDYA)
Biontech Se Sponsored Ads (BNTX)
Vera Therapeutics Cl A (VERA)
Tango Therapeutics (TNGX)
Praxis Precision Medicines I Com New (PRAX)
Celldex Therapeutics Com New (CLDX)
Dianthus Therapeutics (DNTH)
Cg Oncology (CGON)
Disc Medicine (IRON)
Maze Therapeatics (MAZE)
Dyne Therapeutics (DYN)
Moonlake Immunotherapeutics Class A Ord (MLTX)

View all positions for Logos Global Management

Top funds holding Longeveron

Millennium Management
Logos Global Management
Vanguard Capital Management
BlackRock
Geode Capital Management
Jane Street
Vanguard Fiduciary Trust
Mariner Wealth Advisors
ADAR1 Capital Management
Beacon Pointe Advisors
Virtu Financial
Two Sigma Securities
State Street Corporation
Northern Trust
Scotia Capital

View all funds holding Longeveron